2 transcripts
NTRA
Earnings call transcript
NASDAQ
2023 Q4
28 Feb 24
in Women's Health and organ health. Solomon?
Thanks, Steve. Let's start with the Invitae deal. First, recall we secured a judgment on past damages in our
NTRA
Earnings call transcript
NASDAQ
2023 Q2
3 Aug 23
reimbursement. That trend was also apparent in the Signatera clinical ASP, which were once again well ahead of the schedule. Recall the Signatera ASPs were
- Prev
- 1
- Next